Fair-Market Value Compensation Rates for Cardiology KOLs in the United Kingdom

The introduction of the "Fair-Market Value Compensation Rates for Cardiology KOLs - United Kingdom" report aims to provide thought-leader compensation rates for UK-based Key Opinion Leaders (KOLs) in Cardiology. This report establishes fair-market value compensation rates through a methodology that collects data from industry professionals involved in defining compensation levels for exchanges with KOLs worldwide. The report addresses concerns of external perception of inappropriate inducement and regulatory risks.

Key Takeaways:

  • The report provides fair-market value hourly and half-day compensation rates for UK-based KOLs in Cardiology, by percentiles, with averages, for six activities, and for four levels of Thought Leader influences.
  • The four levels of Thought Leader influences are rare, international, national, and local.
  • Activities include general consulting, speaking, and advisory board for commercial and scientific matters.
  • The fair-market value compensation rates are built directly from industry compensation paid to Healthcare Practitioners (HCPs) and Thought Leaders (KOLs).
  • Establishing fair-market value compensation rates will reduce external perception of inappropriate inducement and limit regulatory and compliance risks.
  • The data included in the report are an aggregate of collected data and not individual rates, and companies and individuals who provided the data are not identified to protect their identity.
  • Research shows that less than 25 percent of pharmaceutical organizations begin working with Key Opinion Leaders during or before the clinical phase, and most (63 percent) wait during phases 2 and 3 to start exchanging with Thought Leaders.

Statistics:

  • Less than 25 percent of pharmaceutical organizations work with Key Opinion Leaders during or before the clinical phase.
  • 63 percent of pharmaceutical organizations wait during phases 2 and 3 to start exchanging with Thought Leaders.
  • 4 levels of Thought Leader influences: rare, international, national, and local.
  • 6 activities: general consulting, speaking, advisory board for commercial and scientific matters, consulting scientific/clinical content, consulting commercial content, speaking scientific/clinical content, and speaking commercial content.
  • 4 levels of Thought Leader influences correspond to specific activities: advisory board lead, advisory board non-lead, consulting scientific/clinical content, consulting commercial content, speaking scientific/clinical content, and speaking commercial content.

Sources:

  • ResearchAndMarkets.com
  • ((Comments on this story may be sent to newsdesk@closeupmedia.com))